» Articles » PMID: 38672202

Relationships Between Osteopontin, Osteoprotegerin, and Other Extracellular Matrix Proteins in Calcifying Arteries

Overview
Journal Biomedicines
Date 2024 Apr 27
PMID 38672202
Authors
Affiliations
Soon will be listed here.
Abstract

Osteopontin (OPN) and osteoprotegerin (OPG) are glycoproteins that participate in the regulation of tissue biomineralization. The aim of the project is to verify the hypothesis that the content of OPN and OPG in the aorta walls increases with the development of atherosclerosis and that these proteins are quantitatively related to the main proteins in the extracellular arteries matrix. Quantitative and qualitative analyses of the OPN and OPG content in 101 aorta sections have been conducted. Additionally, an enzyme-linked immunosorbent assay (ELISA) test has been performed to determine the collagen types I-IV and elastin content in the tissues. Correlations between the biochemical data and patients' age/sex, atherosclerosis stages, and calcification occurrences in the tissue have been established. We are the first to report correlations between OPN or OPG and various types of collagen and elastin content (OPG/type I collagen correlation: r = 0.37, = 0.004; OPG/type II collagen: r = 0.34, = 0.007; OPG/type III collagen: r = 0.39, = 0.002, OPG/type IV collagen: r = 0.27, = 0.03; OPG/elastin: r = 0.42, = 0.001; OPN/collagen type I: r = 0.34, = 0.007; OPN/collagen type II: r = 0.52, = 0.000; OPN/elastin: r = 0.61, = 0.001). OPN overexpression accompanies calcium deposit (CA) formation with the protein localized in the calcium deposit, whereas OPG is located outside the CA. Although OPN and OPG seem to play a similar function (inhibiting calcification), these glycoproteins have different tissue localizations and independent expression regulation. The independent expression regulation presumably depends on the factors responsible for stimulating the synthesis of collagens and elastin.

Citing Articles

Predictive nomogram model for severe coronary artery calcification in end-stage kidney disease patients.

Tang X, Qian H, Lu S, Huang H, Wang J, Li F Ren Fail. 2024; 46(2):2365393.

PMID: 38874139 PMC: 11232636. DOI: 10.1080/0886022X.2024.2365393.

References
1.
Rekhter M . Collagen synthesis in atherosclerosis: too much and not enough. Cardiovasc Res. 1999; 41(2):376-84. DOI: 10.1016/s0008-6363(98)00321-6. View

2.
Sbarouni E, Georgiadou P, Chatzikyriakou S, Analitis A, Chaidaroglou A, Degiannis D . Osteopontin in relation to Prognosis following Coronary Artery Bypass Graft Surgery. Dis Markers. 2016; 2016:1868739. PMC: 5002285. DOI: 10.1155/2016/1868739. View

3.
Stepien E, Wypasek E, Stopyra K, Konieczynska M, PRZYBYlO M, Pasowicz M . Increased levels of bone remodeling biomarkers (osteoprotegerin and osteopontin) in hypertensive individuals. Clin Biochem. 2011; 44(10-11):826-31. DOI: 10.1016/j.clinbiochem.2011.04.016. View

4.
Wang Y, Liu Y, Huang Z, Chen X, Zhang B . The roles of osteoprotegerin in cancer, far beyond a bone player. Cell Death Discov. 2022; 8(1):252. PMC: 9076607. DOI: 10.1038/s41420-022-01042-0. View

5.
Kuzan A, Chwilkowska A, Pezowicz C, Witkiewicz W, Gamian A, Maksymowicz K . The content of collagen type II in human arteries is correlated with the stage of atherosclerosis and calcification foci. Cardiovasc Pathol. 2017; 28:21-27. DOI: 10.1016/j.carpath.2017.02.003. View